Liver Disease Due to Schistosoma Guineensis - a Review*
نویسنده
چکیده
No 37. 50. Grácio A, Machado J, Lima C. Neurological schistosomiasis: report of two cases. Oxford 2000 (UK) New Challenges in Tropical Medicine and Parasitology. Poster Abstract No 369. 51. Murinello A, Gonçalves A, Loureiro Ma, van-Dunen F, Alvarenga J, Campos C, Lázaro A, Milheiro A, Carvalho A. Schistosomíase. Aspectos clínicos e histopatológicos da doença (Portuguese). Rev Gastrenterol Cirurg 1998; XV: 53-69. 52. Jatsa HB, Kamtchoing P, Takougang I, Sokeng SD. Testicular dysfunction in BALB C mice with Schistosoma intercalatum bilharziasis. Asian J Androl 2003; 1.064/http://www.asiandro.com/ 1008-682x/4/143.htm. 53. Arnon R. Life span of parasite in schistosomiasis patients (edit.; comment). Israel J Med Sci 1990; 26: 404-5. 54. Hall Sc, Kehoe ES. Prolonged survival of Schistosoma japonicum. Calif Med 1970; 113: 75-7. 55. Markell SF, LoVerde PT, Britt EM. Prolonged latent schistosomiasis. JAMA 1978; 24=: 1746-7. 56. Cioli D. Praziquantel: Is there real resistance and are there alternatives? Curr Opin Infect Dis 2000; 13: 659-63. 57. Gryssel B, Stelma FF, Talla I. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recent exposed community in Senegal. Trop Geog Med 1994; 46: 209-19 58. Ismail M, Botros S, Metwally A, et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 1999; 60: 132-5. 59. Cioli D, Picca-Mattoccia I, Archer S Antischistosomal drugs: past, present and future? Pharmacol Therap 1995; 68: 35-85. 60. Kamel G, Metwally A, Guirguis F, Nessim NG, Noseir M. Effect of a combination of the new antischistosomal drug RO15-5458 and Praziquantel on different strains of Schistosoma mansoni infected mice. Arneim.-Forsch./Drug Res.50(I), Nr.4 (2000). 61. Khattab A, Picca-Mattoccia L, Klinkert MQ, et al Cyclosporin: lack of correlation between antischistosomal properties and inhibition of cyclosporine immune activity. Exp Parasitol 1998; 90: 103-9. 62. Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemoth 2002; 47: 1487-95. 63. Soliman M, Ibrahim M. Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study. Acta Tropica 2005; 93:1-9 64. Davies A. Antischistosomal drugs and clinical practice. In: Jordan P, Webbe G, Sturrock, eds. Human Schistosomiasis. 8th edition. Willingford. UK: CAB International; 1993. p. 367-404. 65. Ripert C, Neves I, Appriou M, Triboley J, Tribouley-Duret J, Haumont G, Guy M, Trouvé B. Épidémiologie de certaines endémies parasitaires dans la ville de Guadalupe (République de São Tomé e Príncipe) 1. Schistosomose à Schistosome intercalatum et verminoses intestinales (French). Bull Soc Pathol Exot 1996 ; 89:252-8. 104 A. MURINELLO ET AL GE Vol.13 88630-Revista_GE_13 06/05/19 16:33 Page 44
منابع مشابه
Natural Interactions between S. haematobium and S. guineensis in the Republic of Benin
Schistosomiasis is a parasitic disease which affects millions of people around the world, particularly in Africa. In this continent, different species are able to interbreed, like Schistosoma haematobium and Schistosoma guineensis, two schistosome species infecting humans. The Republic of Benin is known to harbor S. haematobium, but its geographical situation in between Nigeria, Mali, and Burki...
متن کاملWater Contact Activities and Prevalence of Schistosomiasis Infection among School-age Children in Communities along an Irrigation Scheme in Rural Northern Ghana
Human schistosomiasis, also known as bilharziasis is a complex of acute and chronic parasitic infections caused by mammalian blood flukes belonging to the genus Schistosoma. The disease is endemic in 74 countries with an estimated 200 million people infected, of whom 120 million are symptomatic and 20 million have severe disease. Six hundred million people are at risk of infection [1]. The infe...
متن کاملLifestyle in Non-alcoholic Fatty Liver: A Review
Background: The world is now in the process of passing on health to non-diseases chronic, like non-alcoholic fatty liver (NAFLD) is a major cause of changes in the lifestyle of people. This study aims to evaluate the effects of lifestyle on fatty liver disease (NAFLD). Methods: For this critical review, we identified articles by searching original studies and review articles published in peer ...
متن کاملReview of Natural History, Benefits and Risk Factors Pediatric Liver Transplantation
Liver or hepatic transplantation (LT) is the replacement of a diseased liver with part or whole healthy liver from another person (allograft). Human liver transplants were first performed by Thomas Starzl in the United States and Roy Calne in Cambridge, England in 1963 and 1967, respectively. Liver transplantation is a viable treatment option for end-stage liver disease and acute liver failure....
متن کاملThe chronic enteropathogenic disease schistosomiasis.
Schistosomiasis is a chronic enteropathogenic disease caused by blood flukes of the genus Schistosoma. The disease afflicts approximately 240 million individuals globally, causing approximately 70 million disability-adjusted life years lost. Chronic infections with morbidity and mortality occur as a result of granuloma formation in the intestine, liver, or in the case of Schistosoma haematobium...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2006